BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34900699)

  • 1. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
    Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
    Front Oncol; 2021; 11():752579. PubMed ID: 34900699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma.
    Maturo MG; Rachakonda S; Heidenreich B; Pellegrini C; Srinivas N; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C; Di Nardo L; Peris K; Fargnoli MC; Nagore E; Kumar R
    Sci Rep; 2020 May; 10(1):8005. PubMed ID: 32409749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Molecular Genetics of Basal Cell Carcinoma.
    Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevoid Basal Cell Carcinoma Syndrome:
    Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
    Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent DPH3 promoter mutations in skin cancers.
    Denisova E; Heidenreich B; Nagore E; Rachakonda PS; Hosen I; Akrap I; Traves V; García-Casado Z; López-Guerrero JA; Requena C; Sanmartin O; Serra-Guillén C; Llombart B; Guillén C; Ferrando J; Gimeno E; Nordheim A; Hemminki K; Kumar R
    Oncotarget; 2015 Nov; 6(34):35922-30. PubMed ID: 26416425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in basal cell carcinoma subtypes.
    Di Nardo L; Pellegrini C; Di Stefani A; Ricci F; Fossati B; Del Regno L; Carbone C; Piro G; Corbo V; Delfino P; De Summa S; Maturo MG; Rocco T; Tortora G; Fargnoli MC; Peris K
    Sci Rep; 2021 Jun; 11(1):13206. PubMed ID: 34168209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5'UTR introns on gene expression in Arabidopsis thaliana.
    Chung BY; Simons C; Firth AE; Brown CM; Hellens RP
    BMC Genomics; 2006 May; 7():120. PubMed ID: 16712733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTCH1 gene haplotype association with basal cell carcinoma after transplantation.
    Begnini A; Tessari G; Turco A; Malerba G; Naldi L; Gotti E; Boschiero L; Forni A; Rugiu C; Piaserico S; Fortina AB; Brunello A; Cascone C; Girolomoni G; Gomez Lira M
    Br J Dermatol; 2010 Aug; 163(2):364-70. PubMed ID: 20346027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNA mutations in cancer.
    Zhou H; Hao X; Zhang P; He S
    Wiley Interdiscip Rev RNA; 2023; 14(6):e1812. PubMed ID: 37544928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
    Olsson E; Winter C; George A; Chen Y; Törngren T; Bendahl PO; Borg Å; Gruvberger-Saal SK; Saal LH
    PLoS One; 2015; 10(12):e0144528. PubMed ID: 26670335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer noncoding genomic analysis identifies functional
    He Z; Wu T; Wang S; Zhang J; Sun X; Tao Z; Zhao X; Li H; Wu K; Liu XS
    iScience; 2021 Apr; 24(4):102285. PubMed ID: 33851100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
    Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
    Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted exome sequencing and chromosomal microarray for the molecular diagnosis of nevoid basal cell carcinoma syndrome.
    Matsudate Y; Naruto T; Hayashi Y; Minami M; Tohyama M; Yokota K; Yamada D; Imoto I; Kubo Y
    J Dermatol Sci; 2017 Jun; 86(3):206-211. PubMed ID: 28342698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.
    Fredriksson NJ; Ny L; Nilsson JA; Larsson E
    Nat Genet; 2014 Dec; 46(12):1258-63. PubMed ID: 25383969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids with alternative 5'-untranslated regions are differentially expressed in mouse liver and placenta.
    Southard JN; Barrett BA; Bikbulatova L; Ilkbahar Y; Wu K; Talamantes F
    Endocrinology; 1995 Jul; 136(7):2913-21. PubMed ID: 7789316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
    Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma.
    Thind AS; Ashford B; Strbenac D; Mitchell J; Lee J; Mueller SA; Minaei E; Perry JR; Ch'ng S; Iyer NG; Clark JR; Gupta R; Ranson M
    Front Oncol; 2022; 12():919118. PubMed ID: 35982973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique features of PTCH1 mutation spectrum in Chinese sporadic basal cell carcinoma.
    Huang YS; Bu DF; Li XY; Ma ZH; Yang Y; Lin ZM; Lu FM; Tu P; Li H
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):235-41. PubMed ID: 22313357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
    Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
    Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
    Hafner C; Landthaler M; Vogt T
    Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.